Stock 6L7A BELLEROPHON THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Bellerophon Therapeutics, Inc. Börse Stuttgart

Equities

6L7A

US0787713009

Market Closed - Börse Stuttgart
Other stock markets
 07:01:13 13/10/2023 BST 		5-day change 1st Jan Change
0.421 EUR +20.98% Intraday chart for Bellerophon Therapeutics, Inc. +26.05% -45.08%
05-02 North American Morning Briefing : Stock Futures -2- DJ
04-25 North American Morning Briefing : More Tech -2- DJ

Chart calendar Bellerophon Therapeutics, Inc.

05415abd71.iUQy7UOhWbLZgOWDOWcGC9mZj8WhyCjtZLgw765AL2w.5itanjPQMOCexqnBCBBWOp3K17LEjWCaF9lRuvoSGCm9CwepKNUp--rqgg~f2bb41397868ed141d85adcb8d77d355

Upcoming events on Bellerophon Therapeutics, Inc.

No events available

Past events on Bellerophon Therapeutics, Inc.

08/05/2024 Q1 2024 Earnings Release (Projected)
01/03/2024 16:00 Extraordinary Shareholders Meeting - Restructuring Vote
06/06/2023 Annual General Meeting
05/06/2023 13:30 INOpulse Phase 3 Clinical Trial Results Call
15/05/2023 21:50 Q1 2023 Earnings Release
31/03/2023 13:30 Q4 2022 Earnings Release
14/11/2022 13:30 Q3 2022 Earnings Release
15/08/2022 13:30 Interim 2022 Earnings Release
01/06/2022 15:00 Annual General Meeting
17/05/2022 22:15 American Thoracic Society International Conference
11/05/2022 13:30 Q1 2022 Earnings Release
31/03/2022 21:01 FY 2021 Earnings Release
10/01/2022 12:00 H.C. Wainwright BioConnect Conference
04/01/2022 LifeSci Partners Corporate Access Event
15/11/2021 13:30 Q3 2021 Earnings Release
13/09/2021 13:00 H.C. Wainwright Global Investment Conference
05/08/2021 13:30 Interim 2021 Earnings Release
03/06/2021 20:00 Jefferies Healthcare Conference
25/05/2021 Annual General Meeting
11/05/2021 13:30 Q1 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBIT
Million USD		Released
Forecast
Spread 		-27,9
-31,6
11.75%		-17,5
-18,1
3.55%		-26,3
-26,8
1.92%		-20,2
-21,4
5.57%		-22,4
-22,4
0.05%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-2,63
-10,0
73.78%		-15,1
-15,9
5.24%		-26,9
-27,4
2.12%		-19,6
-20,7
5.71%		-22,2
-22,3
0.05%
Net income
Million USD		Released
Forecast
Spread 		2,81
-4,57
161.52%		-13,3
-14,1
5.92%		-24,7
-26,0
4.95%		-17,8
-18,9
6.25%		-19,8
-19,9
0.35%
EPS
USD		Released
Forecast
Spread 		0,65
-1,20
154.08%		-2,95
-3,00
1.67%		-3,17
-3,34
5.09%		-1,87
-1,94
3.61%		-2,08
-2,03
-2.72%
Announcement Date14/03/1906/04/2011/03/2131/03/2231/03/23

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		5,64
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBIT
Million USD		Released
Forecast
Spread 		-4,80
-6,32
23.94%		-4,27
-5,46
21.74%		-5,64
-5,25
-7.57%		-6,54
-5,79
-12.97%		-5,12
-6,25
18.08%		-5,09
-5,15
1.17%		1,48
-5,78
125.57%		-5,26
-4,40
-19.6%		-2,17
-4,60
52.83%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-4,63
-6,32
26.62%		-4,27
-5,46
21.76%		-5,64
-5,25
-7.55%		-6,52
-5,79
-12.74%		-5,07
-6,25
18.83%		-5,02
-5,15
2.51%		1,55
-5,75
126.85%		-5,14
-4,34
-18.47%		-1,92
-4,58
58.03%
Net income
Million USD		Released
Forecast
Spread 		-4,63
-6,32
26.62%		-4,27
-5,46
21.76%		-5,64
-5,25
-7.55%		-4,11
-5,79
29.04%		-5,07
-6,25
18.83%		-5,02
-5,15
2.51%		2,82
-5,19
154.4%		-5,14
-4,34
-18.47%		-1,92
-4,58
58.03%
EPS
USD		Released
Forecast
Spread 		-0,49
-0,63
22.22%		-0,45
-0,52
13.46%		-0,59
-0,55
-8.26%		-0,43
-0,61
28.93%		-0,53
-0,59
9.4%		-0,53
-0,48
-10.42%		0,27
-0,49
155.1%		-0,42
-0,42
0%		-0,16
-0,44
63.64%
Announcement Date15/11/2131/03/2211/05/2215/08/2214/11/2231/03/2315/05/2314/08/2314/11/23

Upcoming sector events for Bellerophon Therapeutics, Inc.

12/05/2024 PHARMAESSENTIA CORPORATION: Q1 2024 Earnings Release
12/05/2024 ALLOGENE THERAPEUTICS, INC.: Q1 2024 Earnings Release
12/05/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q1 2024 Earnings Release (Projected)
12/05/2024 LEGEND BIOTECH CORPORATION: Q1 2024 Earnings Release
12/05/2024 PEPTRON, INC.: Q1 2024 Earnings Release (Projected)
13/05/2024 IMMATICS N.V.: Q1 2024 Earnings Release (Projected)
13/05/2024 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
13/05/2024 PEPTIDREAM INC.: Q1 2024 Earnings Release
13/05/2024 NYKODE THERAPEUTICS: Q1 2024 Earnings Release
13/05/2024 ABL BIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Bellerophon Therapeutics, Inc.

10/05/2024 21:02 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release
10/05/2024 13:26 ITEOS THERAPEUTICS, INC.: Q1 2024 Earnings Release
10/05/2024 13:00 PRIME MEDICINE, INC.: Q1 2024 Earnings Release
10/05/2024 12:00 AKERO THERAPEUTICS, INC.: Q1 2024 Earnings Release
10/05/2024 01:05 SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release
09/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected)
09/05/2024 21:15 ANAPTYSBIO, INC.: Q1 2024 Earnings Release
09/05/2024 21:10 ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release
09/05/2024 21:09 XENCOR, INC.: Q1 2024 Earnings Release
09/05/2024 21:05 STRUCTURE THERAPEUTICS INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BLPH Stock
  4. 6L7A Stock
  5. Calendar Bellerophon Therapeutics, Inc.